Skip to main content
Clinical Trials/ISRCTN70913605
ISRCTN70913605
Completed
Not Applicable

A study of patients with multi-vessel disease presenting with acute myocardial infarction undergoing primary percutaneous coronary intervention (PPCI) including a prospective registry of all PPCI patients and a pilot study in a subset of patients with multi-vessel coronary disease randomised to a strategy of early multi-vessel revascularisation or infarct related artery revascularisation only

niversity Hospitals of Leicester NHS Trust (UK)0 sites1,250 target enrollmentFebruary 24, 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ST elevation myocardial infarction (STEMI)
Sponsor
niversity Hospitals of Leicester NHS Trust (UK)
Enrollment
1250
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 24, 2011
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity Hospitals of Leicester NHS Trust (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Suspected or proven acute myocardial infarction
  • 2\. Significant ST elevation on electrocardiogram (ECG)
  • 3\. Less than 12 hours of symptom onset
  • 4\. Scheduled for primary percutaneous coronary intervention (PCI) for clinical reasons
  • 5\. Provision of verbal assent followed by written informed consent
  • 1\. Suspected or proven acute myocardial infarction
  • 2\. Significant ST elevation on ECG
  • 3\. Less than 12 hours of symptom onset
  • 4\. Scheduled for Primary PCI for clinical reasons
  • 5\. Provision of verbal assent followed by written informed consent

Exclusion Criteria

  • There are no formal exclusion criteria for the CVLPRIT registry for patients that meet the inclusion criteria.
  • 1\. Any contraindication to PPCI or multi\-vessel PPCI
  • 2\. Less than 18 years age
  • 3\. Clear indication for or contraindication to multivessel PPCI, according to operator judgement and the reasons will be documented
  • 4\. Severe kidney impairment

Outcomes

Primary Outcomes

Not specified

Similar Trials